Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYSLTR2 | Q9NS75 | 3/20 | 0.48 |
| ▸ | CYSLTR1 | Q9Y271 | 3/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.48 |
| ▸ | PDE3B | Q13370 | 2/20 | 0.45 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.45 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.44 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | ALDH2 | P05091 | 2/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
| ▸ | LTA4H | P09960 | 1/20 | 0.39 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.39 |
| ▸ | MTNR1A | P48039 | 3/20 | 0.39 |
| ▸ | MTNR1B | P49286 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10035880 | 0.89 | MEN1 (0.45) | CYSLTR2CYSLTR1PDE3BPDE3AP2RY12 | |
| SCHEMBL660896 | 0.84 | PDK2 (0.52) | CYSLTR2CYSLTR1FFAR1PDE3BPDE3A | |
| SCHEMBL662124 | 0.71 | PDK2 (0.47) | FFAR1PDE3BPDE3AP2RY12PDK2 | |
| SCHEMBL9132945 | 0.70 | CYSLTR2 (0.54) | CYSLTR2CYSLTR1FFAR1PDE3BPDE3A | |
| SCHEMBL4095329 | 0.69 | FFAR1 (0.54) | CYSLTR2CYSLTR1FFAR1PDE3BPDE3A | |
| SCHEMBL14570538 | 0.69 | MEN1 (0.59) | CYSLTR2CYSLTR1FFAR1PDK2MEN1 | |
| SCHEMBL10203017 | 0.69 | BRD4 (0.55) | CYSLTR2CYSLTR1FFAR1PDE3BPDE3A | |
| SCHEMBL15798175 | 0.69 | CYSLTR2 (0.58) | CYSLTR2CYSLTR1FFAR1PDK2ALDH2 | |
| SCHEMBL7632059 | 0.69 | CYSLTR2 (0.64) | CYSLTR2CYSLTR1FFAR1PDE3BPDE3A | |
| SCHEMBL19474670 | 0.68 | LTA4H (0.53) | CYSLTR2CYSLTR1FFAR1PDK2BRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1981846-B1 | MARKERS, METHOD FOR MANUFACTURING THEM AND THEIR APPLICATIONS | LABORATOIRES SYNTH-INNOVE (FR) | 2017-11-01 | — | — | EP | disclosed |
| US-20120045851-A1 | LABELS, THEIR PRODUCTION PROCESS AND THEIR USES | LABORATOIRES SYNTH-INNOVE (FR) | 2012-02-23 | — | — | US | disclosed |
| US-20120045851-A1 | LABELS, THEIR PRODUCTION PROCESS AND THEIR USES | LABORATOIRES SYNTH-INNOVE (FR) | 2012-02-23 | — | — | US | disclosed |
| US-8034626-B2 | Labels, their production process and their uses | LABORATOIRES SYNTH-INNOVE (FR) | 2011-10-11 | — | — | US | disclosed |
| US-8034626-B2 | Labels, their production process and their uses | LABORATOIRES SYNTH-INNOVE (FR) | 2011-10-11 | — | — | US | disclosed |
| US-20080318336-A1 | Labels, Their Production Process And Their Uses | LABORATOIRES SYNTH-INNOVE (FR) | 2008-12-25 | — | — | US | disclosed |
| US-20080318336-A1 | Labels, Their Production Process And Their Uses | LABORATOIRES SYNTH-INNOVE (FR) | 2008-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120045851-A1 | LABELS, THEIR PRODUCTION PROCESS AND THEIR USES | HLCS, PFAS, CYBA | CYSLTR2 2087/4885CYSLTR1 2263/4885FFAR1 3330/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.